Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

$1 Billion Whistleblower Lawsuit Brought Against Quest Diagnostics
CP Wire
Monday, July 11, 2011 - 12:31pm
tags:
Quest Diagnostics, Medicaid, Medicare, Medicare fraud, whistleblower lawsuits
Feds Probe Cephalon For Off-Label Treanda Promotion
Pharmalot
Monday, July 11, 2011 - 12:22pm
tags:
Cephalon, Treanda, off-label, chronic lymphocytic leukemia, DOJ
Qiagen Hikes Cellestis' Offer Price
Yahoo/Zacks.com
Monday, July 11, 2011 - 12:21pm
tags:
Cellestis, Qiagen, M&A, Life Technologies
What Happens After Intermezzo's Likely FDA Approval
Seeking Alpha
Monday, July 11, 2011 - 12:18pm
tags:
Intermezzo, FDA, Transcept, Somaxon, NeurogesX
Merck, Sangamo to Gain From $70 Million Boost in AIDS Cure Hunt
Bloomberg
Monday, July 11, 2011 - 12:17pm
tags:
AIDS, HIV, Merck, Sangamo BioSciences, grants
Amgen widens cancer reach in $1B-plus Micromet deal
Fierce Biotech
Monday, July 11, 2011 - 10:16am
tags:
Amgen, Micromet, cancer
In China, Some Doctors Are Becoming Sales Reps
Pharmalot
Monday, July 11, 2011 - 10:15am
tags:
China, physicians, drug reps
Oncothyreon: Deep Dive Into Stimuvax
Seeking Alpha
Monday, July 11, 2011 - 10:14am
tags:
Stimuvax, Oncothyreon, lung cancer
A Pre-Earnings Look at Cubist Pharma
Seeking Alpha
Monday, July 11, 2011 - 9:55am
tags:
earnings, Cubist Pharmaceuticals
Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
Yahoo
Monday, July 11, 2011 - 9:52am
tags:
Eli Lilly, Pharma CEOs, John Lechleiter
Pfizer Sues Apotex Over Generic Version of Pain Drug Lyrica
Bloomberg
Monday, July 11, 2011 - 9:51am
tags:
Pfizer, Apotex, generics, Lyrica, lawsuits
Looking for a Pullback to Pick Up Johnson & Johnson's Shares
Seeking Alpha
Monday, July 11, 2011 - 9:51am
tags:
JNJ
Sanofi-Genzyme MS Drug: Mixed Results
TheStreet.com
Monday, July 11, 2011 - 9:50am
tags:
MS, multiple sclerosis, Sanofi, Genzyme
Teva settles with Merck over cholesterol drugs
Globes, Israel
Sunday, July 10, 2011 - 11:44am
tags:
Teva Pharmaceuticals, Merck, Vytorin, Zetia
Teva faces 2 key court hearings on Monday
Globes, Israel
Sunday, July 10, 2011 - 11:42am
tags:
Teva Pharmaceuticals, Pfizer, Mylan, Lipitor, Copaxone, legal
Wockhardt gets tentative USFDA nod for anti-depression drug
MoneyControl, India
Sunday, July 10, 2011 - 11:40am
tags:
Wockhardt, Cymbalta, Eli Lilly
Pfizer gets $800m boost for Lipitor
Financial Times, UK
Sunday, July 10, 2011 - 11:36am
tags:
Pfizer, Lipitor, cholesterol
Lilly’s Cialis Seeks to Surpass Pfizer’s Viagra, WiWo Reports
Bloomberg
Sunday, July 10, 2011 - 11:35am
tags:
Eli Lilly, Cialis, Viagra, erectile dysfunction, Pfizer
The Next Big Thing In Biotech: Transcept (video)
The Street
Sunday, July 10, 2011 - 11:33am
tags:
Transcept, Intermezzo, sleep aid, insomnia, Ambien
Amylin to Resubmit Diabetes Treatment to F.D.A.
NY Times
Sunday, July 10, 2011 - 11:28am
tags:
Amylin, Bydureon, diabetes, Eli Lilly, Alkermes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.